Drawing for F.N.O.N. FUNCTIONAL NETWORK-ORIENTED NEUROMODULATION

USPTO serial 79445614

F.N.O.N. FUNCTIONAL NETWORK-ORIENTED NEUROMODULATION

Reviewed by CopyMark Law Group

Reg. 8428893Status 700Registered
Filing date
Status date
Registration date
Sep 15, 2026
Examiner
KHAN, AHSEN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with F.N.O.N. FUNCTIONAL NETWORK-ORIENTED NEUROMODULATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Lazouski

Alexander Lazouski Lazouski IP LLCSuite 1, 14726 Bowfin Ter.Lakewood Ranch, FL 34202United States

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for analyzing brain wave frequencies; medical devices in the nature of medical image processors; medical therapy orthopedic instrumentsACTIVE—
042Providing scientific research information in the field of genetics; providing scientific research information in the field of pharmaceuticals; providing scientific research information and results from an online searchable database; providing scientific information in the field of medical disorders and their treatment; providing information relating to scientific research in the fields of biochemistry and biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; computer aided scientific research services; computer aided scientific analysis services namely chemical laboratory services; scientific research conducted using databases; scientific research and development; scientific and technological design namely engineering; computer aided scientific testing in the nature of engineering; provision of scientific information; scientific advisory services; design and development of computer hardware and software; certification being quality control; industrial research and analysis namely engineering; industrial design services; technological services and research relating thereto, namely, software designACTIVE—
044Pathological testing for diagnostic or treatment purposes; pathological testing for diagnostic and treatment purposes; medical diagnostic services; medical testing for diagnostic or treatment purposes; conducting sleep studies for medical diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical treatment services; medical analysis services; medical evaluation services; medical care services; medical information services; medical advisory services; medical consultancy services; provision of medical services; advisory services relating to medical services; advisory services relating to medical problems; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnosis and treatment of disease; medical and health services relating to dna, genetics and genetic testing; medical evaluation services for patients receiving rehabilitation for purposes of guiding treatment and assessing effectiveness; veterinary services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 30, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 30, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jun 30, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 30, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 29, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2026RFNTREFUSAL PROCESSED BY IB—
May 24, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 23, 2026RFRRREFUSAL PROCESSED BY MPU—
Apr 9, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 8, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2026DOCKASSIGNED TO EXAMINER—
Mar 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 12, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance